Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 12, 2021, titled "press release dated November 12, 2021 titled Zydus Cadila receives tentative approval from USFDA for Eluxadoline Tablets ".
Press Release Nov 12 2021
Filed with NSE · · 2 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Nov 10 2021
- Press Release Nov 08 2021
- Press Release Oct 22 2021
- Press Release Oct 08 2021
- Press Release Sep 24 2021
Later from Zydus Lifesciences
- Press Release Nov 18 2021
- Press Release Nov 20 2021
- Press Release Nov 23 2021
- Press Release Dec 10 2021
- Press Release Dec 13 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences